ICHR vs PLAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

ICHR

64.5
AI Score
VS
PLAB Wins

PLAB

66.0
AI Score

Investment Advisor Scores

ICHR

Sep 12, 2026
65score
Recommendation
HOLD

PLAB

Sep 12, 2026
66score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric ICHR PLAB Winner
Forward P/E 17.094 13.2626 PLAB
PEG Ratio 0.2443 2.6419 ICHR
Revenue Growth 22.7% 2.7% ICHR
Earnings Growth -6.1% 25.6% PLAB
Tradestie Score 64.5/100 66.0/100 PLAB
Profit Margin -4.0% 19.1% PLAB
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

ICHR 1M: -17.1% · 3M: -31.8% PLAB 1M: -13.4% · 3M: -5.7%

Current Technical Phase

ICHR

Markdown
Sell / avoid

Price below a falling SMA50 (slope -13.8%), weak momentum, RSI 43

RSI (14): 43.3 · Price: $57.35

PLAB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.9 · Price: $28.99

Fundamentals Snapshot

Metric ICHR PLAB
Market Cap
Forward P/E 17.6 14.0
Trailing P/E 10.4
Revenue (TTM)
Revenue Growth 0.2% 0.0%
Gross Margin 0.1% 0.3%
Operating Margin 0.0% 0.2%
EPS -1.17 2.74
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PLAB is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.